methoxyhydroxyphenylglycol has been researched along with fluvoxamine in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (62.50) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Den Boer, JA; Westenberg, HG | 1 |
| Baba, T; Lee, JW; Shibuya, T; Takada, K; Takeda, H | 1 |
| Charney, DS; Goddard, AW; Goodman, WK; Heninger, GR; Sholomskas, DE; Woods, SW | 1 |
| Den Boer, JA; Slaap, BR; van Vliet, IM; Westenberg, HG | 1 |
| Bardgett, ME; Csernansky, JG; Sheline, Y | 1 |
| Egashira, T; Matsumiya, T; Takada, K; Takayama, F; Takeda, H; Yamanaka, Y | 1 |
| Nakamura, J; Shinkai, K; Ueda, N; Yoshimura, R | 1 |
| Kaneko, S; Nakamura, J; Shinkai, K; Yoshimura, R | 1 |
5 trial(s) available for methoxyhydroxyphenylglycol and fluvoxamine
| Article | Year |
|---|---|
Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin.
Topics: Adult; beta-Endorphin; Blood Platelets; Double-Blind Method; Fear; Female; Fluvoxamine; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Male; Melatonin; Mental Disorders; Methoxyhydroxyphenylglycol; Norepinephrine; Oximes; Panic; Piperidines; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Ritanserin; Serotonin | 1990 |
Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder.
Topics: Adult; Anxiety; Arousal; Female; Fluvoxamine; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Norepinephrine; Panic; Panic Disorder; Single-Blind Method; Yohimbine | 1993 |
MHPG and heart rate as correlates of nonresponse to drug therapy in panic disorder patients. A preliminary report.
Topics: Adult; Biomarkers; Blood Pressure; Double-Blind Method; Female; Fluvoxamine; Heart Rate; Humans; Hydrocortisone; Male; Methoxyhydroxyphenylglycol; Middle Aged; Monoamine Oxidase Inhibitors; Panic Disorder; Piperidines; Selective Serotonin Reuptake Inhibitors; Treatment Failure | 1996 |
Correlated reductions in cerebrospinal fluid 5-HIAA and MHPG concentrations after treatment with selective serotonin reuptake inhibitors.
Topics: Adult; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Middle Aged; Selective Serotonin Reuptake Inhibitors | 1997 |
Plasma levels of catecholamine metabolites predict the response to sulpiride or fluvoxamine in major depression.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Biomarkers; Depressive Disorder, Major; Dopamine Antagonists; Female; Fluvoxamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sulpiride; Treatment Outcome | 2002 |
3 other study(ies) available for methoxyhydroxyphenylglycol and fluvoxamine
| Article | Year |
|---|---|
[Effect of fluvoxamine, a new antidepressant drug, on monoamine dynamics in the rat cerebral limbic system and its pharmacological characteristic].
Topics: Administration, Oral; Amygdala; Animals; Biogenic Monoamines; Fluvoxamine; Hippocampus; Hydroxyindoleacetic Acid; Imipramine; Limbic System; Male; Methoxyhydroxyphenylglycol; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin | 1995 |
Day/night variation of 5-hydroxyindole acetic acid concentration in rat cerebrospinal fluid after acute and long-term administration of a selective serotonin reuptake inhibitor, fluvoxamine.
Topics: Animals; Circadian Rhythm; Fluvoxamine; Hydroxyindoleacetic Acid; Male; Methoxyhydroxyphenylglycol; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors | 2000 |
Successful treatment for obsessive-compulsive disorder with addition of low-dose risperidone to fluvoxamine: implications for plasma levels of catecholamine metabolites and serum brain-derived neurotrophic factor levels.
Topics: Adult; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Catecholamines; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluvoxamine; Homovanillic Acid; Humans; Male; Methoxyhydroxyphenylglycol; Obsessive-Compulsive Disorder; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists | 2006 |